Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Brian A. Ference"'
Autor:
Kausik K. Ray, Brian A. Ference, Tania Séverin, Dirk Blom, Stephen J. Nicholls, Mariko H. Shiba, Wael Almahmeed, Rodrigo Alonso, Magdalena Daccord, Marat Ezhov, Rosa Fernández Olmo, Piotr Jankowski, Fernando Lanas, Roopa Mehta, Raman Puri, Nathan D. Wong, David Wood, Dong Zhao, Samuel S. Gidding, Salim S. Virani, Donald Lloyd-Jones, Fausto Pinto, Pablo Perel, Raul D. Santos
Publikováno v:
Global Heart, Vol 17, Iss 1 (2022)
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumul
Externí odkaz:
https://doaj.org/article/d76f2dee03ca4cf1b6165d59d556f094
Autor:
Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 5 (2020)
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Externí odkaz:
https://doaj.org/article/85da4c90ec0e40e594dfee9db7ef0e09
Autor:
Natalie Koh, Brian A Ference, Stephen J Nicholls, Ann Marie Navar, Derek P Chew, Karam Kostner, Ben He, Hung Fat Tse, Jamshed Dalal, Anwar Santoso, Junya Ako, Hayato Tada, Jin Joo Park, Mei Lin Ong, Eric Lim, Tavin Subramaniam, Yi-Heng Li, Arintaya Phrommintikul, SS Iyengar, Saumitra Ray, Kyung Woo Park, Hong Chang Tan, Narathip Chunhamaneewat, Khung Keong Yeo, Jack Wei Chieh Tan
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
The prevalence of dyslipidaemia has been increasing in the Asia-Pacific region and this is attributed to dietary changes and decreasing physical activity. While there has been substantial progress in dyslipidaemia therapy, its management in the regio
Externí odkaz:
https://doaj.org/article/c1f1dcf2a27641a285019a0f13e129a2
Autor:
Gian Marco De Marchis, Tolga D. Dittrich, Rainer Malik, Annaelle V. Zietz, Lilian F. Kriemler, Brian A. Ference, Martin Dichgans, Marios K. Georgakis
Publikováno v:
Atherosclerosis. 361:41-46
Post hoc analyses of clinical trials show that PCSK9 inhibitors might lower lipoprotein(a), but whether this effect contributes to reductions in cardiovascular risk remains unknown. We aimed to assess whether genetically proxied PCSK9 inhibition infl
Autor:
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, Brian A. Ference, Benoit J. Arsenault, Lars Berglund, Marc R. Dweck, Marlys L. Koschinsky, Gilles Lambert, François Mach, Catherine J. McNeal, Patrick M. Moriarty, Pradeep Natarajan, Børge G. Nordestgaard, Klaus G. Parhofer, Salim S. Virani, Arnold von Eckardstein, Gerald F. Watts, Jane K. Stock, Kausik K. Ray, Lale S. Tokgözoğlu, Alberico L. Catapano
Publikováno v:
Atherosclerosis.
In 2022, the European Atherosclerosis Society (EAS) published a new consensus statement on lipoprotein(a) [Lp(a)], summarizing current knowledge about its causal association with atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. One
Autor:
Brian A, Ference
Publikováno v:
Journal of the American College of Cardiology. 80:663-665
Autor:
Zanfina Ademi, Jedidiah I. Morton, Danny Liew, Stephen J. Nicholls, Sophia Zoungas, Brian A. Ference
Funder: Monash University
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventions relative to their opportunity cost. However, many health economic
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventions relative to their opportunity cost. However, many health economic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe367853040bbabc6869fa7e06801bd
https://www.repository.cam.ac.uk/handle/1810/341873
https://www.repository.cam.ac.uk/handle/1810/341873
Autor:
Brian A. Ference, Radu Huculeci, Marie-Therese Cooney, Adam Timmis, Ian D. Graham, Panos Vardas, Dirk De Bacquer, Martin Halle, Frank L.J. Visseren, Emanuele Di Angelantonio
Publikováno v:
Journal of the American College of Cardiology. 77:3046-3057
Clinical estimation of the combined effect of several risk factors is unreliable and this resulted in the development of a number of risk estimation systems to guide clinical practice. Here, after defining general principles of risk estimation, the a
Autor:
Gerald F. Watts, Brian A. Ference, Sophia Zoungas, Richard Norman, Zanfina Ademi, Albert Wiegman, Eric J.G. Sijbrands, Danny Liew, Jing Pang
Publikováno v:
Atherosclerosis, 304, 1-8. Elsevier Ireland Ltd
Background There are no studies that have specifically investigated the cost-effectiveness of cascade screening of children for heterozygous familial hypercholesterolemia (FH) and treatment of affected individuals with statins to prevent coronary hea
Autor:
Nicholas A Marston, Robert Giugliano, Giorgio Melloni, Jeong-Gun Park, Brian A Ference, Evan A Stein, Christian T Ruff, Marc S Sabatine
Publikováno v:
Circulation. 144
Background: Lipid management typically focuses on levels of LDL cholesterol (LDL-C) and, to a lesser extent, triglycerides (TG). Basic investigation and genetic studies, however, suggest that the atherogenic particle subpopulations (LDL & VLDL) are s